NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,114 filers reported holding NOVARTIS A G in Q3 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,602,506 | -1.2% | 104,089 | -2.1% | 0.07% | +4.6% |
| Q2 2023 | $10,727,540 | +9.7% | 106,308 | +0.0% | 0.06% | +22.6% |
| Q1 2023 | $9,780,060 | +0.3% | 106,305 | -1.1% | 0.05% | -13.1% |
| Q4 2022 | $9,752,491 | +20.1% | 107,501 | +0.7% | 0.06% | +13.0% |
| Q3 2022 | $8,118,000 | -16.1% | 106,803 | -6.7% | 0.05% | -15.6% |
| Q2 2022 | $9,671,000 | -9.6% | 114,413 | -6.1% | 0.06% | -19.0% |
| Q1 2022 | $10,695,000 | -7.4% | 121,883 | -7.7% | 0.08% | +21.5% |
| Q4 2021 | $11,544,000 | +1.1% | 131,981 | -5.4% | 0.06% | -7.1% |
| Q3 2021 | $11,415,000 | -11.4% | 139,584 | -1.1% | 0.07% | -10.3% |
| Q2 2021 | $12,881,000 | -6.1% | 141,176 | -12.0% | 0.08% | -10.3% |
| Q1 2021 | $13,712,000 | -10.8% | 160,410 | -1.4% | 0.09% | -11.2% |
| Q4 2020 | $15,370,000 | +7.1% | 162,770 | -1.3% | 0.10% | -3.9% |
| Q3 2020 | $14,347,000 | -3.5% | 164,984 | -3.0% | 0.10% | -8.9% |
| Q2 2020 | $14,862,000 | +3.3% | 170,161 | -2.5% | 0.11% | -10.4% |
| Q1 2020 | $14,390,000 | -19.7% | 174,534 | -7.8% | 0.12% | +0.8% |
| Q4 2019 | $17,919,000 | +6.4% | 189,238 | -2.4% | 0.12% | +1.6% |
| Q3 2019 | $16,843,000 | -4.9% | 193,816 | -0.0% | 0.12% | -6.9% |
| Q2 2019 | $17,706,000 | -10.3% | 193,910 | -5.6% | 0.13% | -27.6% |
| Q1 2019 | $19,744,000 | +10.2% | 205,366 | -1.7% | 0.18% | -5.7% |
| Q4 2018 | $17,923,000 | -3.2% | 208,866 | -2.8% | 0.19% | -19.3% |
| Q3 2018 | $18,508,000 | +11.2% | 214,814 | -2.5% | 0.24% | +36.8% |
| Q2 2018 | $16,648,000 | -22.8% | 220,383 | -17.4% | 0.17% | -26.9% |
| Q1 2018 | $21,571,000 | -6.0% | 266,800 | -2.3% | 0.24% | +0.8% |
| Q4 2017 | $22,936,000 | -2.1% | 273,176 | +0.1% | 0.24% | -8.2% |
| Q3 2017 | $23,435,000 | -2.3% | 272,977 | -5.0% | 0.26% | -6.2% |
| Q2 2017 | $23,991,000 | -27.7% | 287,415 | -35.7% | 0.27% | -28.1% |
| Q1 2017 | $33,177,000 | +9.9% | 446,708 | +7.8% | 0.38% | +3.3% |
| Q4 2016 | $30,187,000 | -17.2% | 414,433 | -10.3% | 0.37% | -16.3% |
| Q3 2016 | $36,462,000 | -8.2% | 461,769 | -4.0% | 0.44% | -14.4% |
| Q2 2016 | $39,700,000 | -25.7% | 481,161 | -34.8% | 0.52% | -27.5% |
| Q1 2016 | $53,428,000 | -22.3% | 737,544 | -7.7% | 0.71% | -24.5% |
| Q4 2015 | $68,761,000 | -13.1% | 799,171 | -7.2% | 0.94% | -17.2% |
| Q3 2015 | $79,138,000 | -53.1% | 860,944 | -49.8% | 1.14% | -49.8% |
| Q2 2015 | $168,796,000 | -0.6% | 1,716,460 | -0.3% | 2.27% | -1.4% |
| Q1 2015 | $169,777,000 | +8.9% | 1,721,703 | +2.3% | 2.30% | +5.4% |
| Q4 2014 | $155,966,000 | +0.0% | 1,683,201 | +1.6% | 2.18% | -6.2% |
| Q3 2014 | $155,907,000 | +5.4% | 1,656,289 | +1.4% | 2.32% | +3.3% |
| Q2 2014 | $147,900,000 | +6.2% | 1,633,714 | -0.2% | 2.25% | +0.8% |
| Q1 2014 | $139,220,000 | +5.6% | 1,637,498 | -0.2% | 2.23% | +3.2% |
| Q4 2013 | $131,871,000 | +6.4% | 1,640,604 | +1.5% | 2.16% | -3.0% |
| Q3 2013 | $123,983,000 | +8.2% | 1,616,253 | -0.2% | 2.23% | +3.0% |
| Q2 2013 | $114,548,000 | – | 1,619,965 | – | 2.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |